Company Expression of Interest
Canadian health science companies are invited to submit an expression of interest (EOI) to pitch to global investors at the 2022 OBIO Investment Summit, hosted virtually, on February 9-11, 2022.
The Summit will highlight Canada’s most promising health science companies across a full spectrum of technologies: therapeutics, medical devices and digital health.
EOI Review
Following the review of the EOI, selected companies will be invited to submit a full application including a pitch deck.
Applications to Pitch
Selected companies will pitch virtually to global investors and strategics, and will have access to an online partnering system for networking and 1x1 meetings. The companies selected to pitch will be required to pay a registration fee of $500. However, there is no fee to submit an expression of interest.
Applications will be reviewed on a rolling basis by an expert Selection Committee and need to demonstrate high growth potential and readiness for investment. Presentation review will be available for selected companies.
2022 OBIO Investment Summit eligibility criteria are that the applicant company:
Has operations in Canada
Is focused on developing health science products including but not limited to therapeutics, medical devices, diagnostics, or digital health which fit into the themes of the 2022 OBIO Investment Summit that are outlined on the application form.
Expects to be actively fundraising in February 2022 and plans to close their investment round within 12 months.
The first round of EOI applications are now
being reviewed on a rolling basis.